Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2569 of 5804
-
Gum disease breakthrough? own blood gel may boost healing
Disease control CompletedThe study aims to investigate whether application of albumin platelet-rich fibrin (Alb-PRF) into the gum pockets after scaling and root planing (SRP) can improve healing in patients with Stage III Grade B periodontitis. Periodontitis is a chronic disease that damages the tissues …
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New radioactive compound shows promise in targeting Hard-to-Treat cancers
Disease control CompletedThis is a single-center, non-randomized, single-arm, open-label exploratory clinical study of ¹⁷⁷Lu-CTR-FAPI in patients with FAP-high expressing metastatic solid tumors, with a focus on breast cancer, sarcoma, and thyroid cancer. The purpose of this study is to evaluate the saf…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy targets hard-to-treat GI cancers
Disease control Recruiting nowThis is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression on standard therapy, and to assess correlation of outcomes with the biomarker Trop-2.
Phase: PHASE1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New MRI scan could spare thousands from unnecessary kidney surgery
Diagnosis OngoingThis study investigates whether new types of MRI scans can tell the difference between different kidney tumours before surgery. Currently, imaging scans can detect kidney tumours and their size, but they aren't effective at determining the tumour type or its aggressiveness. Biops…
Phase: NA • Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 26, 2026 17:24 UTC
-
Gut bug may reveal who responds to prostate cancer drug
Knowledge-focused Recruiting nowProstate cancer has the highest incidence and is the second leading cause of cancer death in men in western countries. Androgen deprivation therapy is the backbone treatment. However, after a latency hormone sensitive prostate cancer (HSPC) usually progresses to castration-resist…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New heart valve keeps ticking: study tracks safety and performance
Disease control OngoingThe purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.
Phase: NA • Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Needle vs. scalpel: which dialysis access works best?
Disease control Recruiting nowPatients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type of vascular access is called an arteriovenous fistula (AVF). The AVF is a direct connect between an artery and vein. Un…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Your genes might predict a hidden heart risk
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn whether a genetic risk score can help identify undiagnosed atrial fibrillation (AF) in adults who may have it. AF is an irregular heartbeat that raises the risk of stroke if not treated early. The main questions it aims to answer are: …
Phase: NA • Sponsor: Seoul St. Mary's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Magic mushrooms again? study tests second retreat for cancer anxiety
Symptom relief CompletedThis phase I trial tests the safety and side effects of a second episode of psilocybin-assisted group therapy and how well it works in treating anxiety and distress in patients with cancer that has spread from where it first started (primary site) to other places in the body (met…
Phase: PHASE1 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kids with rare muscle disease: Long-Term drug safety trial begins
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to assess the long-term safety and tolerability of an additional 52 weeks of Zilucoplan treatment administered by subcutaneous injection once daily in pediatric study participants
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New acne gel shows promise in large trial
Symptom relief OngoingThe clinical trial aims to test a new drug for acne vulgaris. The trial is performed to answer this question "Is it possible to reduce the number of skin lesions on your face/trunk, after daily applications for 12 consecutive weeks of a new drug?". The trial aims to accurately me…
Phase: PHASE3 • Sponsor: PPM Services S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New sleep program aims to help kids with epilepsy and their parents rest better
Symptom relief Recruiting nowSleep problems are more common and more severe in children with epilepsy. The purpose of this study is to develop and evaluate the effect of a clinic-based and technology-supported sleep intervention for improving sleep and health in children with epilepsy and their parents.
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Bladder battle: full or empty to ease radiation side effects?
Symptom relief Recruiting nowThe present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.
Phase: PHASE3 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New program aims to help seniors kick the sleeping pill habit
Disease control Recruiting nowAmong older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common. While sleeping pills are effective in the first few weeks of use, their effect diminishes significantly after that. Especially older adu…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New approach helps uninsured patients take control of diabetes
Disease control CompletedThe purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New limpet device aims to stop ostomy leaks and skin woes
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of the Limpet, as compared to standard of care ostomy pouches, in reducing complications for ostomy and fistula patients. Secondary objectives include evaluating dressing leak rates and causes of complica…
Phase: NA • Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Breathwork breakthrough? SKY program may ease cravings in recovery
Symptom relief CompletedEmotional wellness can play a vital role in supporting recovery from substance use disorder (SUD). Developing skills to regulate emotions and manage stress during early stages of recovery can help manage triggers and prevent relapse. Controlled breathing (i.e., intentional manipu…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New study aims to close racial gap in diabetes control
Disease control OngoingThis study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Center clinics.
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain wave test may unlock secrets of chronic pain
Diagnosis OngoingIn this study the investigators aim to assess the correlates of neurophysiological measures (measurement of brain magnetically evoked response) using DELPHI system. The DELPHI system device is a computerized, electromechanical medical device that produces and delivers non-invasiv…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Can a simple supplement quiet tinnitus and save your hearing?
Symptom relief CompletedACEMg (Soundbites) is a neuroprotectant supplement designed to block the initiating biological events in the inner ear leading to inner ear hearing loss, sensorineural hearing loss, SNHL, which accounts for more than 90% of all hearing loss. SNHL is so common it is called hearing…
Phase: NA • Sponsor: Keep Hearing, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC